|
1
|
Sanfilippo KM, McTigue KM, Fidler CJ,
Neaton JD, Chang Y, Fried LF, Liu S and Kuller LH: Hypertension and
obesity and the risk of kidney cancer in 2 large cohorts of US men
and women. Hypertension. 63:934–941. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Frew IJ and Moch H: A clearer view of the
molecular complexity of clear cell renal cell carcinoma. Annu Rev
Pathol. 10:263–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Papale M, Vocino G, Lucarelli G,
Rutigliano M, Gigante M, Rocchetti MT, Pesce F, Sanguedolce F, Bufo
P, Battaglia M, et al: Urinary RKIP/p-RKIP is a potential
diagnostic and prognostic marker of clear cell renal cell
carcinoma. Oncotarget. 8:40412–40424. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Neely BA, Wilkins CE, Marlow LA,
Malyarenko D, Kim Y, Ignatchenko A, Sasinowska H, Sasinowski M,
Nyalwidhe JO, Kislinger T, et al: Proteotranscriptomic analysis
reveals stage specific changes in the molecular landscape of
Clear-cell renal cell carcinoma. PLoS One. 11:e01540742016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gowrishankar B, Ibragimova I, Zhou Y,
Slifker MJ, Devarajan K, Al-Saleem T, Uzzo RG and Cairns P:
MicroRNA expression signatures of stage, grade, and progression in
clear cell RCC. Cancer Biol Ther. 15:329–341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gossage L, Eisen T and Maher ER: VHL, the
story of a tumour suppressor gene. Nat Rev Cancer. 15:55–64. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Escudier B, Szczylik C, Porta C and Gore
M: Treatment selection in metastatic renal cell carcinoma: Expert
consensus. Nat Rev Clin Oncol. 9:327–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mandriota SJ, Turner KJ, Davies DR, Murray
PG, Morgan NV, Sowter HM, Wykoff CC, Maher ER, Harris AL, Ratcliffe
PJ, et al: HIF activation identifies early lesions in VHL kidneys:
Evidence for site-specific tumor suppressor function in the
nephron. Cancer Cell. 1:459–468. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kulasingam V and Diamandis EP: Strategies
for discovering novel cancer biomarkers through utilization of
emerging technologies. Nat Clin Pract Oncol. 5:588–599. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang M, Chen BL, Huang JB, Meng YN, Duan
XJ, Chen L, Li LR and Chen YP: Angiogenesis-related genes may be a
more important factor than matrix metalloproteinases in
bronchopulmonary dysplasia development. Oncotarget. 8:18670–18679.
2017.PubMed/NCBI
|
|
11
|
Xiao J, Liu A, Lu X, Chen X, Li W, He S,
He B and Chen Q: Prognostic significance of TCF21 mRNA expression
in patients with lung adenocarcinoma. Sci Rep. 7:20272017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peterson LE: CLUSFAVOR 5.0: Hierarchical
cluster and principal-component analysis of microarray-based
transcriptional profiles. Genome Biol. 3:SOFTWARE00022002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ito K and Murphy D: Application of ggplot2
to pharmacometric graphics. CPT Pharmacometrics Syst Pharmacol.
2:e792013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Szklarczyk D, Franceschini A, Kuhn M,
Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork
P, et al: The STRING database in 2011: Functional interaction
networks of proteins, globally integrated and scored. Nucleic Acids
Res. 39:(Database Issue). D561–D568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mutwil M, Usadel B, Schütte M, Loraine A,
Ebenhöh O and Persson S: Assembly of an interactive correlation
network for the Arabidopsis genome using a novel heuristic
clustering algorithm. Plant Physiol. 152:29–43. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Interactive human protein atlas launches.
Cancer Discov. 5:3392015. View Article : Google Scholar
|
|
19
|
Anaya J: OncoLnc: Linking TCGA survival
data to mRNAs, miRNAs, and lncRNAs. Peer J Computer Sci. 2:e672016.
View Article : Google Scholar
|
|
20
|
Tian Y, Du W, Cao S, Wu Y, Dong N, Wang Y
and Xu Y: Systematic analyses of glutamine and glutamate
metabolisms across different cancer types. Chin J Cancer.
36:882017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meng X, Zhong J, Liu S, Murray M and
Gonzalez-Angulo AM: A new hypothesis for the cancer mechanism.
Cancer Metastasis Rev. 31:247–268. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mimeault M and Batra SK: Hypoxia-inducing
factors as master regulators of stemness properties and altered
metabolism of cancer- and metastasis-initiating cells. J Cell Mol
Med. 17:30–54. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gorrini C, Harris IS and Mak TW:
Modulation of oxidative stress as an anticancer strategy. Nat Rev
Drug Discov. 12:931–947. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Harris IS, Treloar AE, Inoue S, Sasaki M,
Gorrini C, Lee KC, Yung KY, Brenner D, Knobbe-Thomsen CB, Cox MA,
et al: Glutathione and thioredoxin antioxidant pathways synergize
to drive cancer initiation and progression. Cancer Cell.
27:211–222. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cairns RA and Mak TW: Fire and water:
Tumor cell adaptation to metabolic conditions. Exp Cell Res.
356:204–208. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hakimi AA, Reznik E, Lee CH, Creighton CJ,
Brannon AR, Luna A, Aksoy BA, Liu EM, Shen R, Lee W, et al: An
integrated metabolic atlas of clear cell renal cell carcinoma.
Cancer Cell. 29:104–116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li B, Qiu B, Lee DS, Walton ZE, Ochocki
JD, Mathew LK, Mancuso A, Gade TP, Keith B, Nissim I, et al:
Fructose-1,6-bisphosphatase opposes renal carcinoma progression.
Nature. 513:251–255. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sudarshan S, Karam JA, Brugarolas J,
Thompson RH, Uzzo R, Rini B, Margulis V, Patard JJ, Escudier B and
Linehan WM: Metabolism of kidney cancer: From the lab to clinical
practice. Eur Urol. 63:244–251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang L and Karin M: Mammalian MAP kinase
signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Johnson GL and Lapadat R:
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and
p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang D, Ding Y, Luo WM, Bender S, Qian
CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH, et al:
Inhibition of MAPK kinase signaling pathways suppressed renal cell
carcinoma growth and angiogenesis in vivo. Cancer Res. 68:81–88.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Noordmans GA, Caputo CR, Huang Y, Sheehan
SM, Bulthuis M, Heeringa P, Hillebrands JL, van Goor H and
Korstanje R: Genetic analysis of mesangial matrix expansion in
aging mice and identification of Far2 as a candidate gene. J Am Soc
Nephrol. 24:1995–2001. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Amălinei C, Căruntu ID, Giuscă SE and
Bălan RA: Matrix metalloproteinases involvement in pathologic
conditions. Rom J Morphol Embryol. 51:215–228. 2010.PubMed/NCBI
|
|
34
|
Maguer-Satta V, Besancon R and
Bachelard-Cascales E: Concise review: Neutral endopeptidase (CD10):
A multifaceted environment actor in stem cells, physiological
mechanisms, and cancer. Stem Cells. 29:389–396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stenman M, Laurell A and Lindskog M:
Prognostic significance of serum albumin in patients with
metastatic renal cell carcinoma. Med Oncol. 31:8412014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ray P, Lewin SA, Mihalko LA, Lesher-Perez
SC, Takayama S, Luker KE and Luker GD: Secreted CXCL12 (SDF-1)
forms dimers under physiological conditions. Biochem J.
442:433–442. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ping L, Ding N, Shi Y, Feng L, Li J, Liu
Y, Lin Y, Shi C, Wang X, Pan Z, et al: The Bruton's tyrosine kinase
inhibitor ibrutinib exerts immunomodulatory effects through
regulation of tumor-infiltrating macrophages. Oncotarget.
8:39218–39229. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen I, Mathews-Greiner L, Li D,
Abisoye-Ogunniyan A, Ray S, Bian Y, Shukla V, Zhang X, Guha R,
Thomas C, et al: Transcriptomic profiling and quantitative
high-throughput (qHTS) drug screening of CDH1 deficient hereditary
diffuse gastric cancer (HDGC) cells identify treatment leads for
familial gastric cancer. J Transl Med. 15:922017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Khouzam RA, Molinari C, Salvi S, Marabelli
M, Molinaro V, Orioli D, Saragoni L, Morgagni P, Calistri D and
Ranzani GN: Digital PCR identifies changes in CDH1 (E-cadherin)
transcription pattern in intestinal-type gastric cancer.
Oncotarget. 8:18811–18820. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
van Roy F and Berx G: The cell-cell
adhesion molecule E-cadherin. Cell Mol Life Sci. 65:3756–3788.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
D'Alterio C, Cindolo L, Portella L,
Polimeno M, Consales C, Riccio A, Cioffi M, Franco R, Chiodini P,
Carteni G, et al: Differential role of CD133 and CXCR4 in renal
cell carcinoma. Cell Cycle. 9:4492–4500. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ronconi E, Sagrinati C, Angelotti ML,
Lazzeri E, Mazzinghi B, Ballerini L, Parente E, Becherucci F, Gacci
M, Carini M, et al: Regeneration of glomerular podocytes by human
renal progenitors. J Am Soc Nephrol. 20:322–332. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sagrinati C, Netti GS, Mazzinghi B,
Lazzeri E, Liotta F, Frosali F, Ronconi E, Meini C, Gacci M,
Squecco R, et al: Isolation and characterization of multipotent
progenitor cells from the Bowman's capsule of adult human kidneys.
J Am Soc Nephrol. 17:2443–2456. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bruno S, Bussolati B, Grange C, Collino F,
Graziano ME, Ferrando U and Gamussi G: CD133+ renal progenitor
cells contribute to tumor angiogenesis. Am J Pathol. 169:2223–2235.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bussolati B, Bruno S, Grange C,
Buttiglieri S, Deregibus MC, Cantino D and Camussi G: Isolation of
renal progenitor cells from adult human kidney. Am J Pathol.
166:545–555. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Roland CL, Harken AH, Sarr MG and Barnett
CC Jr: ICAM-1 expression determines malignant potential of cancer.
Surgery. 141:705–707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Usami Y, Ishida K, Sato S, Kishino M,
Kiryu M, Ogawa Y, Okura M, Fukuda Y and Toyosawa S: Intercellular
adhesion molecule-1 (ICAM-1) expression correlates with oral cancer
progression and induces macrophage/cancer cell adhesion. Int J
Cancer. 133:568–578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Buitrago D, Keutgen XM, Crowley M,
Filicori F, Aldailami H, Hoda R, Liu YF, Hoda RS, Scognamiglio T,
Jin M, et al: Intercellular adhesion molecule-1 (ICAM-1) is
upregulated in aggressive papillary thyroid carcinoma. Ann Surg
Oncol. 19:973–980. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tanabe K, Campbell SC, Alexander JP,
Steinbach F, Edinger MG, Tubbs RR, Novick AC and Klein EA:
Molecular regulation of intercellular adhesion molecule 1 (ICAM-1)
expression in renal cell carcinoma. Urol Res. 25:231–238. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Tanabe K, Alexander JP, Steinbach F,
Campbell S, Novick AC and Klein EA: Retroviral transduction of
intercellular adhesion molecule-1 enhances endothelial attachment
of bladder cancer. Urol Res. 25:401–405. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tomita Y, Nishiyama T, Watanabe H,
Fujiwara M and Sato S: Expression of intercellular adhesion
molecule-1 (ICAM-1) on renal-cell cancer: Possible significance in
host immune responses. Int J Cancer. 46:1001–1006. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shi X, Jiang J, Ye X, Liu Y, Wu Q and Wang
L: Prognostic prediction and diagnostic role of intercellular
adhesion molecule-1 (ICAM1) expression in clear cell renal cell
carcinoma. J Mol Histol. 45:427–434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Williamson AJ, Pierce A, Jaworska E, Zhou
C, Aspinall-O'Dea M, Lancashire L, Unwin RD, Abraham SA, Walker MJ,
Cadecco S, et al: A specific PTPRC/CD45 phosphorylation event
governed by stem cell chemokine CXCL12 regulates primitive
hematopoietic cell motility. Mol Cell Proteomics. 12:3319–3329.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Stanford SM, Ahmed V, Barrios AM and
Bottini N: Cellular biochemistry methods for investigating protein
tyrosine phosphatases. Antioxid Redox Signal. 20:2160–2178. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Clark MC, Pang M, Hsu DK, Liu FT, de Vos
S, Gascoyne RD, Said J and Baum LG: Galectin-3 binds to CD45 on
diffuse large B-cell lymphoma cells to regulate susceptibility to
cell death. Blood. 120:4635–4644. 2012. View Article : Google Scholar : PubMed/NCBI
|
